BioAge Labs (BIOA) Operating Expenses (2023 - 2026)

BioAge Labs has disclosed Operating Expenses across 4 years of filings, most recently posting $31.8 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 16.93% year-over-year to $31.8 million; the TTM figure through Jun 2026 stood at $116.6 million (up 22.52% YoY), while the FY2025 annual figure was $101.8 million, up 30.16% from the prior year.
• Operating Expenses came in at $31.8 million for Q2 2026 at BioAge Labs, up from $28.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $31.8 million in Q2 2026 to a low of $9.9 million in Q3 2023.
• Average Operating Expenses over 4 years is $21.9 million, with a median of $25.0 million recorded in 2024.
• Year-over-year, Operating Expenses soared 150.33% in 2024 and gained 1.79% in 2025.
• Over 4 years, Operating Expenses stood at $13.6 million in 2023, then surged by 86.54% to $25.4 million in 2024, then gained by 24.21% to $31.5 million in 2025, then climbed by 0.9% to $31.8 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $31.8 million in Q2 2026, $28.1 million in Q1 2026, and $31.5 million in Q4 2025.